Crispr Therapeutics (NASDAQ:CRSP) Upgraded to Outperform by William Blair

22 Novembre, 2019, 09:40 | Auteur: Therese Cote
  • Crispr Therapeutics (NASDAQ:CRSP) Upgraded to Outperform by William Blair

11/19/2019 - Crispr Therapeutics had its price target raised by analysts at Piper Jaffray Companies from $100.00 to $107.00. Oppenheimer upgraded Crispr Therapeutics from a market perform rating to an outperform rating and set a $65.00 price target for the company in a research note on Tuesday, November 12th. They issued a buy rating and a $64.00 price target for the company. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and fourteen have assigned a buy rating to the company's stock. They now have a positive rating on the stock. CRISPR Therapeutics AG stock price identified moved of 5884.00% from its 52-week maximum price level and marked a change of 2222.00% from its 52-week minimum price level. Some stocks tend always to have high volume, as they are popular among day traders and investors alike. Canaccord Genuity initiated coverage on shares of Crispr Therapeutics in a report on Friday, July 26th.

CRISPR Therapeutics AG stock gained attention from Investors. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform.

The Trend analysis of the Crispr Therapeutics Ag shows that the Company Buy the Trend Signal & having Trend Strength Maximum with the Trend Direction of the Strengthening. The company traded as high as $57.77 and last traded at $57.00, with a volume of 25559 shares changing hands. The stock has a market capitalization of $3.14 billion, a P/E ratio of -17.30 and a beta of 3.15.

Maple Leafs defeat Coyotes in Keefe's debut as coach
Keefe helped revitalize the franchise, and went on to win CHL and OHL Coach of the Year honours in 2014-15. There are going to be moments where it doesn't look great, where it doesn't feel great.

Taylor Swift named music bible's Woman of the Decade
He added: "I think people need to come together and have a conversation because that's not what this is about". I don't like it watching it in politics.

Canada beats Australia to reach Davis Cup semifinals
Spain are already safely through after Rafael Nadal led them to a 3-0 victory over defending champions Croatia on Wednesday. Teams are allowed to have five players but Canada chose not to replace Milos Raonic when he pulled out through injury.

The company's Crispr Therapeutics Ag, NASDAQ has a Weighted Alpha 112.82. The firm's 50-day simple moving average is $44.72 and its 200 day simple moving average is $44.96. The company has a debt-to-equity ratio of 0.06, a quick ratio of 8.32 and a current ratio of 8.32.

Crispr Therapeutics (NASDAQ:CRSP) last posted its earnings results on Monday, October 28th. The company reported $2.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.95) by $3.35. The firm had revenue of $211.93 million for the quarter, compared to the consensus estimate of $6.32 million. CRISPR Therapeutics AG - Common Shares had 5 analyst reports since June 10, 2019 according to SRatingsIntel. As a group, equities research analysts forecast that Crispr Therapeutics AG will post 0.64 earnings per share for the current fiscal year. More interesting news about CRISPR Therapeutics AG (NASDAQ:CRSP) were released by: Fool.com and their article: "There's Yet Another Gene Editing Technique, but It Has 1 Glaring Problem - Motley Fool" published on October 24, 2019 as well as Nasdaq.com's news article titled: "Here's Why CRISPR Therapeutics Stock Is Falling Today - Nasdaq" with publication date: November 21, 2019. The shares were sold at an average price of $55.00, for a total transaction of $412,500.00. Following the completion of the sale, the director now directly owns 7,500 shares of the company's stock, valued at $390,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Institutional investors possessed 75.92% shares of the company and 41.38% shares are owned by insiders. Nikko Asset Management Americas Inc. boosted its position in shares of Crispr Therapeutics by 48.4% in the third quarter. Capital Advisors Inc. OK boosted its stake in Crispr Therapeutics by 121.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Crispr Therapeutics by 13.6% in the third quarter. ARK Investment Management LLC lifted its stake in shares of Crispr Therapeutics by 34.7% in the second quarter. Traynor Capital Management Inc. now owns 6,845 shares of the company's stock worth $280,000 after acquiring an additional 375 shares in the last quarter. Wells Fargo & Company MN now owns 603,905 shares of the company's stock worth $28,443,000 after acquiring an additional 116,540 shares during the last quarter. Finally, D. E. Shaw & Co. Wells Fargo & Company MN raised its position in shares of Crispr Therapeutics by 23.9% in the second quarter. Commonwealth Equity Services LLC now owns 18,201 shares of the company's stock valued at $746,000 after purchasing an additional 386 shares in the last quarter.

Conseillé:



Populaire

United Kingdom election: Jeremy Corbyn launches Labour Party's socialist policy manifesto
The manifesto showed an extra 82.9 billion pounds of spending, matched by 82.9 billion pounds of revenue-raising measures. So can we really afford to do all this?

Ex-Ravens coach: Didn't want to move Lamar Jackson to WR
Mark Ingram II introduced Jackson before the quarterback spoke to the media following Sunday's win over the Houston Texans . He ranks No. 4 in the NFL with a 106.3 passer rating and No. 10 in the league with 788 rushing yards.

Grace Millane trial: New Zealand man found guilty of murdering British backpacker
Prosecutors say the man strangled Millane to death. "It can be at any time during the application of force leading to death". The defence has argued she was alive when the pictures were taken and the Google searches were "random", Justice Moore said.

It’s Colbert karaoke as New Zealand PM hosts US comedian
It is estimated that paid advertising that promotes New Zealand as a destination in a network program in the main U.S. market. Colbert's visit to New Zealand came about after Ardern formally invited him during an appearance on his show .

" J'ai toujours dit non au PSG " — Eden Hazard
Lié au Real Madrid jusqu'en 2024, Hazard n'a donc toujours pas changé d'avis. Je n'avais pas envie de revenir en Ligue 1, et dans un autre club que Lille .

FBI Official Altered Document in Fake Russia Probe
The New York Times, CNN and other outlets have reported that Durham's investigation had become a criminal investigation. The Justice Department has been tight-lipped on outlining exactly what Durham has been looking at.

Humans put into suspended animation for first time
Human brains can survive without oxygen no longer than several minutes before damage turns irreversible. Normally, doctors conducting medical trials require the consent of patients to try out new treatments.

Une loterie propose de gagner un Picasso pour 100 €
Les organisateurs prévoient d'organiser chaque année ce type de loterie au bénéfice de différentes associations humanitaires. Le tableau, valorisé à un million d'euros, s'intitule Nature morte .

California justices reject law requiring Trump tax returns
The bill goes to show just how insane the Democrats can get when handed supermajorities in the state's two legislative bodies. Refusal to do so would keep them off the state's primary ballot, but not apply to general elections.

Charles Schwab in talks to buy TD Ameritrade
CNBC quotes the Financial Times reporting that Schwab would pay $25 billion for TD Ameritrade . Schwab gained 7% in the same period, giving it a stock market value of $57 billion.